Kaiser Foundation Health Plan Inc v. Merck & Company Inc. et al

JOINT STIPULATION AND ORDER REGARDING MULTI-DISTRICT LITIGATION DISCOVERY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Daniel A. Sasse (State Bar No. 236234)
Tiffanie L. McDowell (State Bar No. 288946)
CROWELL & MORING LLP
3 Park Plaza, 20th Floor
Irvine, California 92614
Telephone: 949.263.8400
Facsimile: 949.263.8414
dsasse@crowell.com
tmcdowell@crowell.com
Kent A. Gardiner (pro hac vice forthcoming)
Mark M. Supko (pro hac vice)
CROWELL & MORING LLP
1001 Pennsylvania Avenue NW
Washington, D.C. 20004
Telephone: 202.624.2500
Facsimile: 202.628.5116
kgardiner@crowell.com
msupko@crowell.com
Attorneys for Plaintiff
Kaiser Foundation Health Plan, Inc.
Samuel G. Liversidge
Shaun A. Mathur
Sarah M. Kushner
Gibson, Dunn & Crutcher LLP
333 South Grand Avenue
Los Angeles, California 90071-3197
(213) 229-7000
sliversidge@gibsondunn.com
smkushner@gibsondunn.com
S. Christopher Whittaker
Courtney L. Spears
3161 Michelson Drive
Irvine, California 92612-4412
(949) 451-3800
cwhittaker@gibsondunn.com
cspears@gibsondunn.com
Attorneys for Defendants Merck & Co., Inc.,
Merck Sharp & Dohme LLC (f/k/a Merck
Sharp & Dohme Corp.), Schering-Plough
Corp., and Schering Corp., and MSP
Singapore Company LLC
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA, OAKLAND DIVISION
KAISER FOUNDATION HEALTH PLAN,
INC.,
Plaintiff,
v.
MERCK & COMPANY, INC.; MERCK
SHARP & DOHME CORPORATION;
SCHERING-PLOUGH CORPORATION;
SCHERING CORPORATION; MSP
SINGAPORE COMPANY LLC;
GLENMARK PHARMACEUTICALS LTD.;
AND GLENMARK PHARMACEUTICALS
INC., USA, Defendants.
Case No. 4:21-cv-05497-HSG
[Removed from San Francisco County
Superior Court Case No. CGC-21-592508]
JOINT STIPULATION AND
ORDER REGARDING MULTI-
DISTRICT LITIGATION
DISCOVERY
Jury Trial Demanded
Case 4:21-cv-05497-HSG Document 116 Filed 02/13/26 Page 1 of 6

1
JOINT STIPULATION AND ORDER REGARDING MULTI-DISTRICT LITIGATION DISCOVERY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Plaintiff Kaiser Foundation Health Plan, Inc. (“Kaiser”) and Defendants Merck &
Company, Inc., Merck, Sharp & Dohme Corporation, Schering-Plough Corporation, and Schering
Corporation (collectively, “Merck” and together with Kaiser, the “Parties”) are taking discovery in
the present litigation involving antitrust allegations;
WHEREAS litigations involving similar antitrust allegations previously were consolidated
in the multi-district litigation action In re: Zetia (Ezetimibe) Antitrust Litigation, MDL No. 2:18-
md-2836 (E.D. Va.) (“MDL”);
WHEREAS certain plaintiffs’ actions were first consolidated in the MDL on June 15, 2018;
WHEREAS Kaiser’s case (the present litigation) was consolidated in the MDL on
September 21, 2021;
WHEREAS Kaiser was an opt-out plaintiff in the MDL and its case was remanded to the
District Court of Northern California on December 13, 2023;
WHEREAS the Parties seek to streamline discovery and reduce the burden by avoiding
discovery in this litigation that is duplicative of the discovery taken in the MDL to the extent
possible; and
THEREFORE, THE PARTIES HEREBY AGREE AND STIPULATE THAT:
1. 	The Parties agree not to object to a Party’s use of any evidence obtained through
discovery during the pendency of the MDL from June 15, 2018 to December 13, 2023 (the “MDL
Period”) on the basis that the evidence was obtained through discovery during the MDL Period.
The Parties otherwise reserve all rights to object to the admissibility of such evidence based on the
Federal Rules of Evidence or on any other grounds.
IT IS SO STIPULATED.
Case 4:21-cv-05497-HSG Document 116 Filed 02/13/26 Page 2 of 6

2
JOINT STIPULATION AND ORDER REGARDING MULTI-DISTRICT LITIGATION DISCOVERY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Dated: February 12, 2026 	Respectfully submitted,
CROWELL & MORING LLP
/s/ Daniel A. Sasse
Daniel A. Sasse (State Bar No. 236234)
Tiffanie L. McDowell (State Bar No. 288946)
CROWELL & MORING LLP
3 Park Plaza, 20th Floor
Irvine, California 92614
Telephone: 949.263.8400
Facsimile: 949.263.8414
dsasse@crowell.com
tmcdowell@crowell.com
Kent A. Gardiner (pro hac vice forthcoming)
Mark M. Supko (pro hac vice)
CROWELL & MORING LLP
1001 Pennsylvania Avenue NW
Washington, D.C. 20004
Telephone: 202.624.2500
Facsimile: 202.628.5116
kgardiner@crowell.com
msupko@crowell.com
Attorneys for Plaintiff Kaiser Foundation Health
Plan, Inc.
Dated: February 12, 2026 	/s/ Shaun A. Mathur
Samuel G. Liversidge, SBN 180578
Shaun A. Mathur, SBN 311029
Sarah M. Kushner, SBN 320077
GIBSON DUNN & CRUTCHER LLP
333 South Grand Avenue
Los Angeles, California 90071-3197
(213) 229-7000
sliversidge@gibsondunn.com
smkushner@gibsondunn.com
S. Christopher Whittaker, SBN 283518
Courtney L. Spears, SBN 329521
GIBSON DUNN & CRUTCHER LLP
3161 Michelson Drive
Irvine, California 92612-4412
(949) 451-3800
cwhittaker@gibsondunn.com
cspears@gibsondunn.com
Attorneys for Defendants Merck & Co., Inc.,
Merck Sharp & Dohme LLC (f/k/a Merck Sharp
& Dohme Corp.), Schering-Plough Corp., and
Schering Corp., and MSP Singapore Company
LLC
Case 4:21-cv-05497-HSG Document 116 Filed 02/13/26 Page 3 of 6

3
JOINT STIPULATION AND ORDER REGARDING MULTI-DISTRICT LITIGATION DISCOVERY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
ATTESTATION PER Civil L.R. 5-1(i)(3)
I attest that concurrence in the filing of the document has been obtained from each of the
other signatories indicated by a conformed signature (/s/) within this e-filed document.
Dated: February 12, 2026 	/s/ Daniel A. Sasse
Daniel A. Sasse
Case 4:21-cv-05497-HSG Document 116 Filed 02/13/26 Page 4 of 6

4
JOINT STIPULATION AND ORDER REGARDING MULTI-DISTRICT LITIGATION DISCOVERY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
CERTIFICATE OF SERVICE
I hereby certify that on February 12, 2026, I electronically filed the foregoing document
with the Clerk of the Court using the Court’s CM/ECF system, which will send a notice of
electronic filing to all CM/ECF participants.
/s/ Daniel A. Sasse
Daniel A. Sasse
Case 4:21-cv-05497-HSG Document 116 Filed 02/13/26 Page 5 of 6

5
JOINT STIPULATION AND ORDER REGARDING MULTI-DISTRICT LITIGATION DISCOVERY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
ORDER
The Court, having reviewed the above Stipulation of Plaintiff and Defendants and good
cause appearing therefore, ORDERS as follows:
1. 	The Parties may not object to a Party’s use of any evidence obtained through
discovery during the pendency of the MDL from June 15, 2018 to December 13, 2023 (the “MDL
Period”) on the basis that the evidence was obtained through discovery during the MDL Period.
The Parties otherwise reserve all rights to object to the admissibility of such evidence based on
the Federal Rules of Evidence or on any other grounds.
PURSUANT TO STIPULATION, IT IS SO ORDERED.
Dated: 2/13/2026
Hon. Haywood S. Gilliam, Jr.
Case 4:21-cv-05497-HSG Document 116 Filed 02/13/26 Page 6 of 6